Sarah Watson

2.4k total citations
18 papers, 868 citations indexed

About

Sarah Watson is a scholar working on Toxicology, Infectious Diseases and Surgery. According to data from OpenAlex, Sarah Watson has authored 18 papers receiving a total of 868 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Toxicology, 3 papers in Infectious Diseases and 3 papers in Surgery. Recurrent topics in Sarah Watson's work include Pharmacovigilance and Adverse Drug Reactions (9 papers), Drug-Induced Adverse Reactions (3 papers) and Pharmaceutical Economics and Policy (3 papers). Sarah Watson is often cited by papers focused on Pharmacovigilance and Adverse Drug Reactions (9 papers), Drug-Induced Adverse Reactions (3 papers) and Pharmaceutical Economics and Policy (3 papers). Sarah Watson collaborates with scholars based in Sweden, United Kingdom and Netherlands. Sarah Watson's co-authors include Ola Caster, Hester M. den Ruijter, Paula A. Rochon, Albert Hofman, Christie M. Ballantyne, Emanuele Di Angelantonio, Chris J. Packard, Stephen Kaptoge, Alexander Thompson and Rory Collins and has published in prestigious journals such as The Lancet, Geophysical Journal International and British Journal of Clinical Pharmacology.

In The Last Decade

Sarah Watson

14 papers receiving 844 citations

Peers

Sarah Watson
Carlos Alves Portugal
Diogo Mendes Portugal
Mitsutaka Takada Japan
Christian Leporini Italy
Charles M. Gerrits United States
Gabriella di Mauro Italy
Tsugumichi Sato Japan
Naomi Gronich Israel
Tjark Reblin Germany
Yasutomi Kinosada Japan
Carlos Alves Portugal
Sarah Watson
Citations per year, relative to Sarah Watson Sarah Watson (= 1×) peers Carlos Alves

Countries citing papers authored by Sarah Watson

Since Specialization
Citations

This map shows the geographic impact of Sarah Watson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah Watson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah Watson more than expected).

Fields of papers citing papers by Sarah Watson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sarah Watson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah Watson. The network helps show where Sarah Watson may publish in the future.

Co-authorship network of co-authors of Sarah Watson

This figure shows the co-authorship network connecting the top 25 collaborators of Sarah Watson. A scholar is included among the top collaborators of Sarah Watson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sarah Watson. Sarah Watson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Bots, Sophie H., Jeanine E. Roeters van Lennep, Sarah Watson, et al.. (2022). Sex Differences in Reported Adverse Drug Reactions to Angiotensin-Converting Enzyme Inhibitors. JAMA Network Open. 5(4). e228224–e228224. 15 indexed citations
2.
Watson, Sarah, et al.. (2022). Montelukast and Nightmares: Further Characterisation Using Data from VigiBase. Drug Safety. 45(6). 675–684. 5 indexed citations
3.
Watson, Sarah, Kathryn Puxty, David Morrison, et al.. (2021). Association Between Anesthetic Dose and Technique and Oncologic Outcomes After Surgical Resection of Non-Small Cell Lung Cancer. Journal of Cardiothoracic and Vascular Anesthesia. 35(11). 3265–3274. 4 indexed citations
4.
Masson, Steven, Rhiannon Taylor, Julie Whitney, et al.. (2021). A coordinated national UK liver transplant program response, prioritizing waitlist recipients with the highest need, provided excellent outcomes during the first wave of the COVID‐19 pandemic. Clinical Transplantation. 36(4). e14563–e14563. 6 indexed citations
5.
6.
Watson, Sarah, et al.. (2021). Characterization of VigiBase reports on tinnitus associated with bisoprolol—An exploratory and descriptive study. Pharmacology Research & Perspectives. 9(3).
7.
8.
9.
Watson, Sarah, et al.. (2020). Sex Differences in Reported Adverse Drug Reactions to COVID-19 Drugs in a Global Database of Individual Case Safety Reports. Drug Safety. 43(12). 1309–1314. 24 indexed citations
10.
Watson, Sarah, Ola Caster, Paula A. Rochon, & Hester M. den Ruijter. (2019). Reported adverse drug reactions in women and men: Aggregated evidence from globally collected individual case reports during half a century. EClinicalMedicine. 17. 100188–100188. 161 indexed citations
11.
Watson, Sarah & Linda Härmark. (2018). Desogestrel and panic attacks – a new suspected adverse drug reaction reported by patients and health care professionals on spontaneous reports. British Journal of Clinical Pharmacology. 84(8). 1858–1859. 6 indexed citations
12.
Watson, Sarah, Rebecca E. Chandler, H. Taavola, et al.. (2017). Safety Concerns Reported by Patients Identified in a Collaborative Signal Detection Workshop using VigiBase: Results and Reflections from Lareb and Uppsala Monitoring Centre. Drug Safety. 41(2). 203–212. 36 indexed citations
13.
Caster, Ola, et al.. (2017). vigiRank for statistical signal detection in pharmacovigilance: First results from prospective real‐world use. Pharmacoepidemiology and Drug Safety. 26(8). 1006–1010. 24 indexed citations
14.
Star, Kristina, et al.. (2015). Longitudinal medical records as a complement to routine drug safety signal analysis. Pharmacoepidemiology and Drug Safety. 24(5). 486–494. 12 indexed citations
15.
Caster, Ola, Kristina Juhlin, Sarah Watson, & G. Niklas Norén. (2014). A Paradigm Shift for Screening Individual Case Reports : Accounting for Quality and Content. Pharmacoepidemiology and Drug Safety. 23. 37–37. 1 indexed citations
16.
Caster, Ola, Kristina Juhlin, Sarah Watson, & G. Niklas Norén. (2014). Improved Statistical Signal Detection in Pharmacovigilance by Combining Multiple Strength-of-Evidence Aspects in vigiRank. Drug Safety. 37(8). 617–628. 82 indexed citations
17.
Thompson, Alexander, Pei Gao, Lia Orfei, et al.. (2010). Lipoprotein-associated phospholipase A2 and risk of coronary disease, stroke, and mortality: collaborative analysis of 32 prospective studies. The Lancet. 375(9725). 1536–1544. 481 indexed citations
18.
Watson, Sarah & Marc Spiegelman. (1994). Geochemical Effects of Magmatic Solitary Waves-I. Numerical Results. Geophysical Journal International. 117(2). 284–295. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Carlos Alves Breakdown of academic impact, for papers by Diogo Mendes Breakdown of academic impact, for papers by Mitsutaka Takada Breakdown of academic impact, for papers by Christian Leporini Breakdown of academic impact, for papers by Charles M. Gerrits Breakdown of academic impact, for papers by Gabriella di Mauro Breakdown of academic impact, for papers by Tsugumichi Sato Breakdown of academic impact, for papers by Naomi Gronich Breakdown of academic impact, for papers by Tjark Reblin Breakdown of academic impact, for papers by Yasutomi Kinosada
Rankless by CCL
2026